Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

SCID MICE ENGRAFT HUMAN STEM CELLS

Feb. 28, 1992

BLECH COMPANIES AGREE TO $50M MERGER

Feb. 28, 1992

EPIGEN PACT FOR CARCINOMA ANTIGEN

Feb. 28, 1992

SKIN SUBSTITUTE SCORES WELL IN TESTS

Feb. 28, 1992

LTIZ FILES SECONDARY OFFERING

Feb. 28, 1992

CORTECH SPIN-OFF RAISES $8.5 MILLION

Feb. 28, 1992

COR BEGINS PHASE II TRIALS OF ANGINA DRUG

Feb. 28, 1992

REPLIGEN/MERCK BUY-BACK COMPLETED

Feb. 27, 1992

U.S. BIOSCIENCE SETS FDA MEETING

Feb. 27, 1992

INTERNEURON LICENSES PARKINSON'S COMPOUND

Feb. 27, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...